Voya Investment Management LLC Point Biopharma Global Inc. Transaction History

Voya Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.67 - $9.71 $4,949 - $7,204	742 Added 2.06%	36,733 $245,000
Q2 2023 Aug 14, 2023	BUY	$6.86 - $10.86 $26,966 - $42,690	3,931 Added 12.26%	35,991 $326,000
Q4 2022 Feb 14, 2023	BUY	$5.72 - $9.78 $14,586 - $24,939	2,550 Added 8.64%	32,060 $233,000
Q3 2022 Mar 03, 2023	SELL	$7.24 - $10.31 $18,462 - $26,290	-2,550 Reduced 7.95%	29,510 $228,000
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $10,621 - $15,124	1,467 Added 5.23%	29,510 $228,000
Q2 2022 Aug 15, 2022	BUY	$5.6 - $9.5 $157,040 - $266,408	28,043 New	28,043 $191,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.